Literature DB >> 23958193

Cell-derived microparticles: new targets in the therapeutic management of disease.

Ariane Roseblade1, Frederick Luk, Tristan Rawling, Alison Ung, Georges E R Grau, Mary Bebawy.   

Abstract

Intercellular communication is essential to maintain vital physiological activities and to regulate the organism's phenotype. There are a number of ways in which cells communicate with one another. This can occur via autocrine signaling, endocrine signaling or by the transfer of molecular mediators across gap junctions. More recently communication via microvesicular shedding has gained important recognition as a significant pathway by which cells can coordinate the spread and dominance of selective traits within a population. Through this communication apparatus, cells can now acquire and secure a survival advantage, particularly in the context of malignant disease. This review aims to highlight some of the functions and implications of microparticles in physiology of various disease states, and present a novel therapeutic strategy through the regulation of microparticle production.

Entities:  

Mesh:

Year:  2013        PMID: 23958193     DOI: 10.18433/j3989x

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  13 in total

Review 1.  Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling.

Authors:  Jesús Villar; Haibo Zhang; Arthur S Slutsky
Journal:  Chest       Date:  2018-10-28       Impact factor: 9.410

2.  Extracellular vesicle-mediated long-range communication in stressed retinal pigment epithelial cell monolayers.

Authors:  Navjot Shah; Masakii Ishii; Carlene Brandon; Zsolt Ablonczy; Jingwen Cai; Yutao Liu; C James Chou; Bärbel Rohrer
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-21       Impact factor: 5.187

3.  Synthesis and in vitro biological evaluation of thiosulfinate derivatives for the treatment of human multidrug-resistant breast cancer.

Authors:  Ariane Roseblade; Alison Ung; Mary Bebawy
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

Review 4.  Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?

Authors:  Richard Callaghan; Frederick Luk; Mary Bebawy
Journal:  Drug Metab Dispos       Date:  2014-02-03       Impact factor: 3.922

5.  A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.

Authors:  Pavani Chalasani; Marilyn Marron; Denise Roe; Kathryn Clarke; Maria Iannone; Robert B Livingston; Joseph S Shan; Alison T Stopeck
Journal:  Cancer Med       Date:  2015-03-31       Impact factor: 4.452

6.  Bystander effects elicited by single-cell photo-oxidative blue-light stimulation in retinal pigment epithelium cell networks.

Authors:  Masaaki Ishii; Bärbel Rohrer
Journal:  Cell Death Discov       Date:  2017-02-06

7.  Anchoring dipalmitoyl phosphoethanolamine to nanoparticles boosts cellular uptake and fluorine-19 magnetic resonance signal.

Authors:  Sonia Waiczies; Stefano Lepore; Karl Sydow; Susanne Drechsler; Min-Chi Ku; Conrad Martin; Dorothea Lorenz; Irene Schütz; Henning M Reimann; Bettina Purfürst; Matthias A Dieringer; Helmar Waiczies; Margitta Dathe; Andreas Pohlmann; Thoralf Niendorf
Journal:  Sci Rep       Date:  2015-02-12       Impact factor: 4.379

Review 8.  Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.

Authors:  Deep Pokharel; Ariane Roseblade; Vici Oenarto; Jamie F Lu; Mary Bebawy
Journal:  Ecancermedicalscience       Date:  2017-09-18

9.  Honey bee hemocyte profiling by flow cytometry.

Authors:  William J Marringa; Michael J Krueger; Nancy L Burritt; James B Burritt
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

10.  N-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial Cells.

Authors:  Kyle A Carver; Dongli Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.